Overview
Benjamin Newton is an Oncologist and an Internal Medicine provider in Waterford, Connecticut. Dr. Newton is rated as an Experienced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Familial Colorectal Cancer, and Colorectal Cancer.
His clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
230 Waterford Pkwy S, Waterford, CT 06385
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Hartford Hospital
Kin Hung is a Hematologist Oncology specialist and a Hematologist in Hartford, Connecticut. Dr. Hung is rated as an Advanced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. His top areas of expertise are Laryngeal Cancer, Throat Cancer, Glioma, and Nasopharyngeal Carcinoma.
Hartford Hospital
Benjamin Chu is a Hematologist Oncology specialist and a Hematologist in Hartford, Connecticut. Dr. Chu is rated as a Distinguished provider by MediFind in the treatment of Nasopharyngeal Carcinoma. His top areas of expertise are Lung Adenocarcinoma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC).
Stony Brook Internists University Faculty Practice Corporation
Achuta Guddati is a Hematologist and an Oncologist in Stony Brook, New York. Dr. Guddati is rated as an Advanced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. His top areas of expertise are Sickle Cell Disease, Bone Tumor, Adult Soft Tissue Sarcoma, Gastrostomy, and Bone Marrow Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Colorectal CancerDr. Newton isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Newton isDistinguished. Learn about Familial Colorectal Cancer.
- Lung CancerDr. Newton isDistinguished. Learn about Lung Cancer.
- Small Cell Lung Cancer (SCLC)Dr. Newton isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- AnemiaDr. Newton isAdvanced. Learn about Anemia.
- Autoimmune Hemolytic AnemiaDr. Newton isAdvanced. Learn about Autoimmune Hemolytic Anemia.
- B-Cell LymphomaDr. Newton isAdvanced. Learn about B-Cell Lymphoma.
- Breast CancerDr. Newton isAdvanced. Learn about Breast Cancer.
- Carcinoid SyndromeDr. Newton isAdvanced. Learn about Carcinoid Syndrome.
- Experienced
- Acquired HemophiliaDr. Newton isExperienced. Learn about Acquired Hemophilia.
- Acute Eosinophilic PneumoniaDr. Newton isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Mountain SicknessDr. Newton isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Newton isExperienced. Learn about Acute Myeloid Leukemia (AML).